Libros importados hasta 50% OFF + Envío Gratis a todo USA   Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (in English)
Type
Physical Book
Publisher
Year
2019
Language
English
Pages
244
Format
Paperback
ISBN13
9780128185506
Edition No.
1
Categories

Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (in English)

Kristine E. Shields (Author) · Academic Press · Paperback

Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (in English) - Kristine E. Shields

Physical Book

$ 142.86

$ 178.57

You save: $ 35.71

20% discount
  • Condition: New
It will be shipped from our warehouse between Monday, July 15 and Tuesday, July 16.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Pregnancy and the Pharmaceutical Industry: The Movement Towards Evidence-Based Pharmacotherapy for Pregnant Women (in English)"

Pregnancy and the Pharmaceutical Industry: The Movement towards Evidence-Based Care for Pregnant Women explores the issues surrounding the decision to undertake clinical trials with pregnant women. There is currently a lack of data on the safety and effectiveness of medications used during pregnancy as it is impossible to extrapolate that information from drug studies on men and non-pregnant women. As a majority of pregnant women confront a medical condition during their pregnancy, from simple pain, to ongoing or new medical issues, this book quantifies the current absence of pregnant women in drug studies and identifies ethical issues, barriers, litigation fears and opportunities. Those in the pharmaceutical industry, IRB members who approve or deny drug study plans, doctors, nurses and midwives working in obstetrics or involved in conducting studies at their institutions will find this book an essential resource.Explores the medical, ethical, scientific and legal rationales behind the inclusion of pregnant women in drug studiesDescribes how pharma and biotech companies can safely implement the new FDA guidance and begin to include pregnant women in drug testingShares views from pharmaceutical industry insiders about company risks, reluctance to implement guidance, and the ultimate need to include pregnant women in studies

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews